253 related articles for article (PubMed ID: 16908399)
1. Toxic epidermal necrolysis and intravenous immunoglobulin: a review.
Trent J; Halem M; French LE; Kerdel F
Semin Cutan Med Surg; 2006 Jun; 25(2):91-3. PubMed ID: 16908399
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
French LE; Trent JT; Kerdel FA
Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
[TBL] [Abstract][Full Text] [Related]
3. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
4. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Sidwell RU; Swift S; Yan CL; Porter W; Thompson EM; Clark JA; Bunker CB
Int J Clin Pract; 2003 Sep; 57(7):643-5. PubMed ID: 14529073
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Khalili B; Bahna SL
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis (Lyell's disease).
Lissia M; Mulas P; Bulla A; Rubino C
Burns; 2010 Mar; 36(2):152-63. PubMed ID: 19766401
[TBL] [Abstract][Full Text] [Related]
7. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).
Paquet P; Piérard GE; Quatresooz P
Int Arch Allergy Immunol; 2005 Mar; 136(3):205-16. PubMed ID: 15713983
[TBL] [Abstract][Full Text] [Related]
8. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
[TBL] [Abstract][Full Text] [Related]
9. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Simeone F; Rubio ER
J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
[TBL] [Abstract][Full Text] [Related]
10. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
Abe R
J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
[TBL] [Abstract][Full Text] [Related]
13. IVIG for the treatment of toxic epidermal necrolysis.
Mittmann N; Chan BC; Knowles S; Shear NH
Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
[TBL] [Abstract][Full Text] [Related]
14. Treatment of toxic epidermal necrolysis (TEN) with low dose intravenous immunoglobulin in child.
Habib A; Pasha W; Raza N
J Coll Physicians Surg Pak; 2010 Mar; 20(3):205-7. PubMed ID: 20392387
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human intravenous immunoglobulin.
Romanelli P; Schlam E; Green JB; Trent JT; Ricotti C; Elgart GW; Kirsner RS; Kerdel FA
G Ital Dermatol Venereol; 2008 Aug; 143(4):229-33. PubMed ID: 18833079
[TBL] [Abstract][Full Text] [Related]
16. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.
French LE
Allergol Int; 2006 Mar; 55(1):9-16. PubMed ID: 17075281
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
Teo L; Tay YK; Liu TT; Kwok C
Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
[TBL] [Abstract][Full Text] [Related]
18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
19. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
20. [Lyell's syndrome in an AIDS patient].
Quintas S; do Carmo G; Gama R; Norberto A; Xavier R; Coutinho BS
Acta Med Port; 1997; 10(6-7):509-16. PubMed ID: 9341046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
